These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1184732)

  • 1. Production of influenza virus complement-fixing antibody in mouse ascitic fluid.
    White LA; Gamble WC; Chappell WA
    J Clin Microbiol; 1975 Oct; 2(4):287-91. PubMed ID: 1184732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New virus-specific antigens in cells infected with influenza virus.
    Dimmock NJ
    Virology; 1969 Oct; 39(2):224-34. PubMed ID: 4981077
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production of hyperimmune sera and immune ascitic fluids to influenza virus protein M by immunization with a protein-polyelectrolyte conjugate].
    Petrov RV; Khaitov RM; Bukrinskaia AG; Nekrasov AV; Liozner AL
    Vopr Virusol; 1984; 29(3):271-3. PubMed ID: 6464423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid complement fixation technique for estimating complement-fixing antigen elution profiles of viruses from gel filtration columns.
    Cornesky RA; Hammon WM; Sather GE; Atchison R
    Appl Microbiol; 1972 Jul; 24(1):157-9. PubMed ID: 5057370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urea on the hemagglutinating and complement-fixing antigens of type 2 Dengue virus.
    Cornesky RA; Hammon WM; Atchison RW; Sather GE
    Infect Immun; 1972 Dec; 6(6):952-7. PubMed ID: 4674080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adjuvant vaccines on dengue virus type 2 immune ascitic fluid production.
    Gamble WC; George EH; Fears MB; Sanderlin DW; Chappell WA
    J Clin Microbiol; 1985 Mar; 21(3):452-3. PubMed ID: 3980697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic and immunogenic activity of influenza virus virion components].
    Milovidova NI; Porubel' LA; Ginzburg VP; Gendon IuZ
    Vopr Virusol; 1974; (6):683-8. PubMed ID: 4446567
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of cells producing surface antigen-specific antibody to influenza viruses.
    McLaren C; Grubbs GE; Ennis FA
    J Clin Microbiol; 1978 Oct; 8(4):438-44. PubMed ID: 363742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accumulation of specific foot-and-mouth disease virus antibodies in the ascitic fluid of white rats].
    Ravilov AZ; Shafikova RA; Sharafutdinova KN
    Vopr Virusol; 1973; 18(4):458-61. PubMed ID: 4362264
    [No Abstract]   [Full Text] [Related]  

  • 10. Volume production of reference seed virus and immune ascitic fluids for six arboviruses.
    Feild J; Kalter SS
    Appl Microbiol; 1972 Feb; 23(2):382-8. PubMed ID: 5017678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single radial complement fixation test for assaying antibody to influenza virus type-specific antigens.
    Yamane N; Yuki M; Nakamura Y
    J Clin Microbiol; 1983 Oct; 18(4):837-43. PubMed ID: 6415098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the single radial diffusion test for assay of antibody to influenza type A viruses.
    Mostow SR; Schild GC; Dowdle WR; Wood RJ
    J Clin Microbiol; 1975 Dec; 2(6):531-40. PubMed ID: 812886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic variants of influenza B virus.
    Schild GC; Pereira MS; Chakraverty P; Coleman MT; Dowdle WR; Chang WK
    Br Med J; 1973 Oct; 4(5885):127-31. PubMed ID: 4201694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antibody to dengue soluble complement-fixing (SCF) antigens.
    Falkler WA; Diwan AR; Halstead SB
    J Immunol; 1973 Dec; 111(6):1804-9. PubMed ID: 4201557
    [No Abstract]   [Full Text] [Related]  

  • 15. Elimination of repeated clot formation in mouse ascitic fluid containing arbovirus antibodies.
    Chiewsilp D; McCown JM
    Appl Microbiol; 1972 Aug; 24(2):288-9. PubMed ID: 4672320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific and nonspecific factors of humoral immunity in the early period of influenza virus immunization].
    Kulevich EE
    Vopr Virusol; 1973; 18(4):438-43. PubMed ID: 4786165
    [No Abstract]   [Full Text] [Related]  

  • 17. Mouse immune ascitic fluids--a source of specific globulins for immunofluorescent staining with arboviruses.
    Gajdamovic SJ; Svesnikova NA; Poljakova AN; Sahanina KL
    Bull World Health Organ; 1973; 49(5):471-3. PubMed ID: 4606821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cell type and virus upon virus-specific immune cytolysis.
    Brandt WE; Russell PK
    Infect Immun; 1975 Feb; 11(2):330-3. PubMed ID: 803470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific and nonspecific cell-mediated resistance to influenza virus in mice.
    Shayegani M; Lief FS; Mudd S
    Infect Immun; 1974 Jun; 9(6):991-8. PubMed ID: 4275386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient production of large volumes of immune ascitic fluid from mice.
    Deig EF
    Arch Gesamte Virusforsch; 1974; 45(1-2):155-6. PubMed ID: 4413191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.